SQA Regulatory Surveillance Summary | Monthly Update 2022 – June
SQA
SEPTEMBER 2, 2022
ANVISA published the RDC 702/2022, which repeals some requirements that were instituted to speed market approval of devices needed to treat patients during the height of the COVID-19 pandemic. The Agency recently published the first list of critical medicines for the management of the COVID-19 pandemic.
91 
Let's personalize your content